Fractures, Open
1
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Colorado TherapeuticsCO - Louisville
2 programs1
VancomycinPhase 41 trial
Formal Operative TreatmentN/A
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Colorado TherapeuticsVancomycin
aap ImplantateImplantation
Angeles TherapeuticsFormal Operative Treatment
Clinical Trials (3)
Total enrollment: 523 patients across 3 trials
Acute Application of Antibiotic Powder in Open Fracture Wounds
Start: Jun 2021Est. completion: Sep 202320 patients
Phase 4Completed
LOQTEQ® Antibacterial Pre-Market Study
Start: Dec 2021Est. completion: Aug 2025203 patients
N/ACompleted
The Treatment of Type I Open Fractures in Pediatrics
Start: Mar 2010Est. completion: Jun 2026300 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 523 patients
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.